Provided by Tiger Trade Technology Pte. Ltd.

Tyra Biosciences, Inc.

19.94
-0.0300-0.15%
Post-market: 19.940.00000.00%19:30 EDT
Volume:649.44K
Turnover:13.10M
Market Cap:1.37B
PE:-8.30
High:20.59
Open:19.93
Low:19.73
Close:19.97
52wk High:40.65
52wk Low:13.29
Shares:68.76M
Float Shares:40.01M
Volume Ratio:0.88
T/O Rate:1.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4031
EPS(LYR):-2.0125
ROE:-45.31%
ROA:-28.46%
PB:3.88
PE(LYR):-9.91

Loading ...

Stock Track | Tyra Biosciences Plummets 5.08% Intraday After Wolfe Research Initiates Coverage with Peer Perform Rating

Stock Track
·
May 20

Tyra Biosciences Initiated at Peer Perform by Wolfe Research

Dow Jones
·
May 19

Tyra Biosciences initiated with a Peer Perform at Wolfe Research

TIPRANKS
·
May 19

Is Tyra Biosciences’ (TYRA) Dabogratinib 3×3 Focus Reframing Its Risk Reward Profile?

Simply Wall St.
·
May 16

Jefferies Reaffirms Their Buy Rating on Tyra Bioscience (TYRA)

TIPRANKS
·
May 14

Bank of America Securities Keeps Their Buy Rating on Tyra Bioscience (TYRA)

TIPRANKS
·
May 14

Tyra Biosciences Price Target Maintained With a $45.00/Share by HC Wainwright & Co.

Dow Jones
·
May 14

Tyra Bioscience (TYRA) Gets a Buy from Barclays

TIPRANKS
·
May 14

Tyra Biosciences reports Q1 EPS (64c), consensus (59c)

TIPRANKS
·
May 14

Analysts Have Conflicting Sentiments on These Healthcare Companies: West Pharmaceutical Services (WST), CalciMedica (CALC) and Tyra Bioscience (TYRA)

TIPRANKS
·
May 13

Earnings Flash (TYRA) Tyra Biosciences Posts Q1 Net Loss $0.64 a Share, vs. FactSet Est of $0.59 Loss

MT Newswires Live
·
May 13

Tyra Biosciences Q1 EPS $(0.64) Misses $(0.59) Estimate

Benzinga Earnings
·
May 13

Tyra Biosciences Q1 FY26 net loss widens to $39.31 million

Reuters
·
May 13

Tyra Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights

THOMSON REUTERS
·
May 13

Tyra Biosciences Inc: Cash, Cash Equivalents and Marketable Securities of $383.5 Mln at Q1 2026; Runway Into 2H 2028

THOMSON REUTERS
·
May 13

Tyra Biosciences Q1 EPS USD -0.64

THOMSON REUTERS
·
May 13

Tyra Biosciences Q1 Operating Expenses USD 41.998 Million

THOMSON REUTERS
·
May 13

Tyra Biosciences to present at BofA Securities Health Care Conference

Reuters
·
May 08

How TYRA-300 Bladder Cancer Data and New Trial Partnership Will Impact Tyra Biosciences (TYRA) Investors

Simply Wall St.
·
May 06

Does Tyra Biosciences (TYRA) Board Refresh and Dabogratinib Spotlight Reframe Its Pipeline Credibility?

Simply Wall St.
·
Apr 27